Thrax Management’s Imperva, Inc. IMPV Stock Holding History

Thrax Management’s Portfolio IMPV Stock Details IMPV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-26,000	Closed	-$1.65M	–	146
2015 Q4	$1.65M	Buy	+26,000	New	+$1.77M	0.34%	54

Other funds holding IMPV

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

CCI

Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return

Thrax Management's IMPV Position: Q1 2016 in Review

Thrax Management sold out of Imperva, Inc. (IMPV) in Q1 2016, closing a stake of 26,000 shares — an estimated $1.65M sold.

Thrax Management first reported a position in IMPV in Q4 2015 and held it in 1 quarter. The position peaked at $1.65M in Q4 2015. 160 funds tracked by Wall St. Rank hold IMPV as of Q1 2016.

Thrax Management reported no remaining Imperva, Inc. position as of Q1 2016 after selling out during the quarter.
Thrax Management sold 26,000 Imperva, Inc. shares in Q1 2016, an estimated $1.65M.
Thrax Management first reported a position in Imperva, Inc. in Q4 2015 and held it in 1 quarter.
Thrax Management's Imperva, Inc. position peaked at $1.65M in Q4 2015.
160 funds tracked by Wall St. Rank held Imperva, Inc. as of Q1 2016.

Based on Thrax Management's 13F filing for Q1 2016, filed 16 May 2016.